Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Cormorant Asset Management
company
About
Cormorant Asset Management is an employee-owned hedge fund sponsor that provides its services to pooled investment vehicles.
- 1 - 10
Highlights
Details
- Industries
- Asset Management,Finance,Financial Services
- Founded date
- Feb 21, 2013
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Investor Type
- Hedge Fund
Cormorant Asset Management is an employee-owned hedge fund sponsor that provides its services to pooled investment vehicles. The firm also focuses on both public and private market innovative companies in the biotechnology and life sciences marketplace.Cormorant Asset Management was founded in 2013 and is based in Boston, Massachusetts, United States.
Investments
Number of Investments
Number of Lead Investments
21
3
Cormorant Asset Management has made 21 investments. Their most recent investment was on
Aug 12, 2022, when Greenlight Biosciences raised $109M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Aug 12, 2022
Greenlight Biosciences
|
Post-IPO Equity | $109M | Agriculture | — |
|
Apr 19, 2022
Tessera Therapeutics
|
Series C | $300M | Biopharma | — |
|
Feb 16, 2022
Star Therapeutics
|
Series Unknown | $100M | — | |
|
Feb 3, 2022
Greenlight Biosciences
|
Post-IPO Equity | $125.50M | Agriculture | — |
|
Jul 13, 2021
Prime Medicine
|
Series B | $200M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
